We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter Presents Virtual Showcase of MicroScan Microbiology Solutions

By LabMedica International staff writers
Posted on 25 Apr 2022
Print article
Image: MicroScan WalkAway plus System for ID/AST testing (Photo courtesy of Beckman Coulter)
Image: MicroScan WalkAway plus System for ID/AST testing (Photo courtesy of Beckman Coulter)

Beckman Coulter (Brea, CA, USA) demonstrated how laboratories can improve patient outcomes with accurate detection of antimicrobial resistance and enhance workflow efficiency with its MicroScan microbiology solutions at ECCMID 2022.

Emerging antimicrobial resistance continues to be a critical issue in today’s healthcare environment. Resistance that was once considered unusual is now routine, and the microbiology laboratory has increasingly many ways, including rapid methods, to test for antimicrobial resistance. Beckman Coulter’s integrated symposium at ECCMID 2022 examined the central role of susceptibility testing and the determination of MICs in a variety of laboratory health care settings. Topics examined included new mechanisms of resistance, laboratory testing protocols and standardization across organizations, and the importance of MICs as well as SIR categories in defining antibiotic treatment, particularly with new antibiotics.

In addition, Beckman Coulter displayed its full suite of MicroScan microbiology solutions designed for every laboratory through its virtual showcase in 3D. Among its innovations for managing emerging microbial resistance that were presented virtually was the company’s DxM MicroScan WalkAway ID/AST System for the detection of emerging and critical antimicrobial resistance with gold-standard1 MIC accuracy. Designed with ease of use as a focal point, this bacterial identification and antimicrobial susceptibility testing (ID/AST) system provides streamlined workflows and enhanced performance compared to its predecessors. It enables laboratories to optimize patient care while reducing risks, costs and operational burden associated with detecting emerging antimicrobial resistance.

Related Links:
Beckman Coulter 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Gold Member
Veterinary Hematology Analyzer
Exigo H400
New
RNA Isolation Kits
RNeasy Plus Kits for RNA Isolation
New
Microplates
Eppendorf Microplates

Print article

Channels

Immunology

view channel
Image: The blood test for fungal infections provides faster results and has a less invasive process (Photo courtesy of 123RF)

Blood Test for Fungal Infections Could End Invasive Tissue Biopsies

For individuals with weakened immune systems, common molds found in the environment—such as in the soil, on damp walls, or on forgotten fruits—can lead to severe infections deep within the body.... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Pathology

view channel
Image: The plasma cell dataset was created to assist in the accurate diagnosis (Photo courtesy of Shutterstock)

Novel Dataset of Plasma Cells to Aid Diagnosis of Multiple Myeloma

Myeloma is a rare blood cancer that originates in plasma cells, a type of immune cell responsible for producing antibodies that help fight infections. The disease begins when an abnormal plasma cell starts... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.